N-(4-hydroxyphenyl) retinamide (4HPR) enhances TRAIL-mediated apoptosis through enhancement of a mitochondrial-dependent amplification loop in ovarian cancer cell lines
- 6 February 2004
- journal article
- Published by Springer Nature in Cell Death & Differentiation
- Vol. 11 (5), 527-541
- https://doi.org/10.1038/sj.cdd.4401387
Abstract
No abstract availableKeywords
This publication has 58 references indexed in Scilit:
- Synergistic Induction of Apoptosis by the Combination of TRAIL and Chemotherapy in Chemoresistant Ovarian Cancer CellsGynecologic Oncology, 2001
- Prolonged Wild-Type p53 Protein Accumulation and Cisplatin ResistanceBiochemical and Biophysical Research Communications, 2001
- Adenovirus-Mediated p53 Growth Inhibition of Ovarian Cancer Cells Is Independent of Endogenous p53 StatusGynecologic Oncology, 1999
- Locoregional Apo2L/TRAIL Eradicates Intracranial Human Malignant Glioma Xenografts in Athymic Mice in the Absence of NeurotoxicityBiochemical and Biophysical Research Communications, 1999
- Safety and antitumor activity of recombinant soluble Apo2 ligandJournal of Clinical Investigation, 1999
- Retinoid X Receptor-Antagonistic Diazepinylbenzoic Acids.CHEMICAL & PHARMACEUTICAL BULLETIN, 1999
- Bcl-xLIs Expressed in Ovarian Carcinoma and Modulates Chemotherapy-Induced ApoptosisGynecologic Oncology, 1998
- Caspases: killer proteasesTrends in Biochemical Sciences, 1997
- Biochemical Pathways of Retinoid Transport, Metabolism, and Signal TransductionClinical Immunology and Immunopathology, 1996
- Sensitization of Human Ovarian Tumor Cells by Subtoxic CDDP to Anti-Fas Antibody-Mediated Cytotoxicity and ApoptosisGynecologic Oncology, 1996